Fig. 6: Survival of ctDNA-positive A031201 patients. | Nature Communications

Fig. 6: Survival of ctDNA-positive A031201 patients.

From: AR alterations inform circulating tumor DNA detection in metastatic castration resistant prostate cancer patients

Fig. 6

Kaplan-Meier plots of (a) radiographic progression-free survival and (b) overall survival in patients classified as ctDNA-positive or ctDNA-negative. Kaplan-Meier plots of (c) radiographic progression-free survival and (d) overall survival in patients classified as belonging to ctDNA aneuploidy-high Group 1, ctDNA aneuploidy-low Group 2, or ctDNA-negative Group 3.

Back to article page